10.85 USD
↘ 0.17 (1.54%)AT CLOSE (03:59 PM EDT)
PUMA BIOTECHNOLOGY INC
PBYINASDAQ • USD
10.91
↗ 0.06 (0.55%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
10.91
↗ 0.06 (0.55%)
Market: OPEN
PUMA BIOTECHNOLOGY INC (PBYI) trades at $10.91 per share. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". This is driven by a concerning Altman Z-Score in the distress zone, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics suggest PBYI is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Oct 26, 2026.
Open?$11.11
High?$11.32
Low?$10.73
Prev. Close?$11.02
Volume?355.7K
Avg. Volume?344.8K
VWAP?$10.92
Rel. Volume?1.03x
Bid / Ask
Bid?$9.27 × 100
Ask?$13.53 × 100
Spread?$4.26
Midpoint?$11.40
Valuation & Ratios
Market Cap?568.9M
Shares Out?51.6M
Float?39.2M
Float %?75.9%
P/E Ratio?21.29
P/B Ratio?4.11
EPS?$0.52
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
Employees
179
Market Cap
568.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2012-03-21
Address
10880 WILSHIRE BLVD.
LOS ANGELES, CA
Phone: (424) 248-6500
LOS ANGELES, CA
Phone: (424) 248-6500
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?77
Z-Score?1
Momentum?88
Short Sent.?23
Piotroski F-Score?6/9Mixed
Altman Z-Score?-0.68Distress
Confidence?51%Low
Short InterestVery High
Short % of Float?11.58%High
Short Interest?4.5M
Days to Cover?12.9
Free Float39.2M
Avg Daily Volume352.6K
Settlement Date2026-10-15
Financial Health
Current Ratio?2.91Strong
Quick Ratio?2.64Strong
Cash Ratio?0.73Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 3 peers + S&P 500
Score83/100
P/E?21.3FAIR▾
Peers50
S&P61
P/B?4.11FAIR▾
Peers50
S&P43
P/S?2.46CHEAP▾
Peers100
S&P58
P/FCF?13.8CHEAP▾
Peers100
S&P78
EV/EBITDA?13.0FAIR▾
Peers50
S&P62
EV/Sales?2.30CHEAP▾
Peers100
S&P70
Returns & Efficiency
ROE?19.3%STRONG▾
Peers50
S&P64
ROA?13.9%STRONG▾
Peers50
S&P84
Cash Flow & Enterprise
FCF?$41.1M
Enterprise Value?$532.3M
Fundamentals ratios updated end of day